Luminex logo

LMNX - Luminex News Story

$36.71 -0.1  -0.2%

Last Trade - 16/04/21

Sector
Healthcare
Size
Mid Cap
Market Cap £1.23bn
Enterprise Value £1.15bn
Revenue £301.8m
Position in Universe 2378th / 6850

BRIEF-Luminex Submits Emergency Use Authorization Request To U.S. FDA For Covid-19 Antibody Test

Mon 29th June, 2020 10:22pm
June 29 (Reuters) - Luminex Corp  LMNX.O :
    * LUMINEX SUBMITS EMERGENCY USE AUTHORIZATION REQUEST TO
U.S. FDA
FOR COVID-19 ANTIBODY TEST
    * LUMINEX CORP - PLANS TO LAUNCH RESEARCH USE ONLY (RUO)
VERSION
OF ASSAY LATER THIS MONTH
    * LUMINEX - ASSAY USES MULTIPLEXING FOR HIGHLY SPECIFIC AND
SENSITIVE DETECTION OF IGG ANTIBODIES AGAINST SARS-COV-2
    * LUMINEX  - ASSAY RUNS ON ALL XMAP® PLATFORMS, GOLD
STANDARD FOR
MULTIPLEX SEROLOGICAL TESTING, AND DETECTS PREVIOUS INFECTION

Source text for Eikon:  ID:nPn5HxBgBa 
Further company coverage:  LMNX.O 

 (Reuters.Briefs@thomsonreuters.com)
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.